CompletedNCT05178316
JZP150 in Adults With PTSD
This study is completed in the United States. It is testing JZP150 for PTSD.
Multiple locations, including PhoenixPTSDDrugA study involving a medication or substance.From 18 Years to 70 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT04113551
Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan
This study is completed in the United States. It is testing label Compliance for ADHD.
In TitusvilleADHDOther
TerminatedNCT01307800
LY2140023 in people with Schizophrenia
This study was terminated in the United States, in Mexico, in Russia, .... It is testing LY2140023 for schizophrenia.
Multiple locations, including WichitaSchizophreniaOtherFrom 18 Years to 65 Years
CompletedNCT01052103
LY2140023 in Schizophrenia people with Prominent Negative Symptoms
This study is completed in the United States, in Israel, in Italy, .... It is testing LY2140023 for schizophrenia.
Multiple locations, including Garden GroveSchizophreniaOtherFrom 18 Years to 65 Years
CompletedNCT05953740
MK-5720 in people with Schizophrenia (MK-5720-001)
This study is completed in the United States. It is testing MK-5720 for schizophrenia.
Multiple locations, including GlendaleSchizophreniaOtherFrom 18 Years to 60 Years
CompletedNCT01174355
ND0801 in Attention Deficit/Hyperactivity Disorder (ADHD)
This study is completed in Israel. It is testing ND0801 for ADHD.
Multiple locations, including HaifaADHDOtherFrom 18 Years to 55 Years
Active Not RecruitingNCT06792136
ONO-1110 in people with Major Depressive Disorder
This study is active but not recruiting in Japan. It is testing ONO-1110 for depression.
Multiple locations, including FukuokaDepressionOtherFrom 18 Years to 65 Years
Active Not RecruitingNCT06805565
ONO-1110 in people with Social Anxiety Disorder
This study is active but not recruiting in Japan. It is testing ONO-1110 for anxiety.
Multiple locations, including FukuokaAnxietyOtherFrom 18 Years to 65 Years
CompletedNCT03345342
Paliperidone Palmitate 6-Month Formulation
This study is completed in the United States, in Australia, in France, .... It focuses on Schizophrenia.
Multiple locations, including RogersSchizophreniaOtherFrom 18 Years to 70 Years
CompletedNCT02699086
PDC-1421 Treatment for ADHD
This study is completed in the United States. It is testing PDC-1421 Treatment for ADHD.
In San FranciscoADHDOtherFrom 18 Years to 70 Years
TerminatedNCT00965419
Pediatric people with Attention Deficit/Hyperactivity Disorder
This study was terminated in the United States, in Canada, and in Taiwan. It focuses on ADHD.
Multiple locations, including Spring ValleyADHDOtherFrom 6 Years to 18 Years
CompletedNCT00922636
Pediatric people with Attention Deficit/Hyperactivity Disorder
This study is completed in the United States and in Canada. It focuses on ADHD.
Multiple locations, including Spring ValleyADHDOtherFrom 6 Years to 17 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.